This is a great buy at the moment as long as they can manage their cash.
Sales force being out of action in field is a concern but they are selling to specialists not GPs. The challenges in sales activity should be much smaller than for traditional pharma sales teams.
This is a great buy at the moment as long as they can manage...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.12 |
Change
-0.050(1.58%) |
Mkt cap ! $219.7M | |||
| Open | High | Low | Value | Volume |
| $3.15 | $3.15 | $3.09 | $174.0K | 55.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 221 | $3.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.13 | 399 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |